DB:9EH

Stock Analysis Report

Executive Summary

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States.

Snowflake

Fundamentals

Adequate balance sheet with reasonable growth potential.

Risks

  • Evolent Health has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has Evolent Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.9%

DB:9EH

1.5%

DE Healthcare Services

0.8%

DE Market


1 Year Return

-67.4%

DB:9EH

4.6%

DE Healthcare Services

-10.9%

DE Market

9EH underperformed the Healthcare Services industry which returned 4.6% over the past year.

9EH underperformed the Market in Germany which returned -10.9% over the past year.


Share holder returns

9EHIndustryMarket
7 Day5.9%1.5%0.8%
30 Day15.3%-23.7%-5.3%
90 Day-48.5%-11.8%-3.2%
1 Year-67.4%-67.4%5.5%4.6%-8.1%-10.9%
3 Year-69.6%-69.6%41.2%36.8%10.4%0.9%
5 Yearn/a176.0%152.6%25.5%8.1%

Price Volatility Vs. Market

How volatile is Evolent Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Evolent Health undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Evolent Health's share price is below the future cash flow value, and at a moderate discount (> 20%).

Evolent Health's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Evolent Health is loss making, we can't compare its value to the DE Healthcare Services industry average.

Evolent Health is loss making, we can't compare the value of its earnings to the Germany market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Evolent Health, we can't assess if its growth is good value.


Price Based on Value of Assets

Evolent Health is good value based on assets compared to the DE Healthcare Services industry average.


Next Steps

Future Growth

How is Evolent Health expected to perform in the next 1 to 3 years based on estimates from 13 analysts?

71.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Evolent Health's revenue is expected to grow by 13.7% yearly, however this is not considered high growth (20% yearly).

Evolent Health's earnings are expected to grow significantly at over 20% yearly.

Evolent Health's revenue growth is expected to exceed the Germany market average.

Evolent Health's earnings growth is expected to exceed the Germany market average.

Evolent Health's earnings growth is expected to exceed the low risk savings rate of 0.2%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Evolent Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Evolent Health performed over the past 5 years?

-41.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Evolent Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Evolent Health's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Evolent Health's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Evolent Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Evolent Health has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Evolent Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Evolent Health's financial position?


Financial Position Analysis

Evolent Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Evolent Health's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Evolent Health's level of debt (19.7%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Evolent Health's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1.1x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Evolent Health has sufficient cash runway for 1.2 years based on current free cash flow.

Evolent Health has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 0.6% each year.


Next Steps

Dividend

What is Evolent Health's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Evolent Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Evolent Health's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Evolent Health has not reported any payouts.

Unable to verify if Evolent Health's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Evolent Health has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Evolent Health's dividends in 3 years as they are not expected to pay a notable one for Germany.


Next Steps

Management

What is the CEO of Evolent Health's salary, the management and board of directors tenure and is there insider trading?

3.5yrs

Average management tenure


CEO

Frank Williams (52yo)

8.0yrs

Tenure

US$3,311,000

Compensation

Mr. Frank J. Williams co-founded Evolent Health, Inc. in 2011 and serves as its Chief Executive Officer since August 2011. Mr. Williams is a Director at Business Talent Group, LLC and Peer Health Exchange. ...


CEO Compensation Analysis

Frank's remuneration is higher than average for companies of similar size in Germany.

Frank's compensation has increased whilst company is loss making.


Management Age and Tenure

3.5yrs

Average Tenure

50yo

Average Age

The tenure for the Evolent Health management team is about average.


Board Age and Tenure

3.8yrs

Average Tenure

60.5yo

Average Age

The tenure for the Evolent Health board of directors is about average.


Insider Trading

More shares have been bought than sold by Evolent Health individual insiders in the past 3 months.


Recent Insider Transactions

BuyUS$45,65019 Aug 19
Kenneth Samet
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares7,200
Max PriceUS$6.34
BuyUS$110,85514 Aug 19
Michael D’Amato
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares10,000
Max PriceUS$11.09
BuyUS$94,00913 Aug 19
Michael D’Amato
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares15,000
Max PriceUS$6.27

Ownership Breakdown


Management Team

  • Norman Payson (70yo)

    • Tenure: 0.2yrs
    • Compensation: US$430.46k
  • Frank Williams (52yo)

    Co-Founder

    • Tenure: 8.0yrs
    • Compensation: US$3.31m
  • Nicky McGrane (51yo)

    Executive Vice President of Corporate Performance

    • Tenure: 0.1yrs
    • Compensation: US$1.01m
  • Jordan Flynn

    VP & Chief Compliance Officer

    • Tenure: 3.0yrs
  • Seth Blackley (40yo)

    Co-Founder

    • Tenure: 1.3yrs
    • Compensation: US$2.21m
  • Tom Peterson (49yo)

    Co-Founder & COO

    • Tenure: 8.6yrs
    • Compensation: US$1.09m
  • Jonathan Weinberg (51yo)

    Chief Legal Officer

    • Tenure: 3.5yrs
    • Compensation: US$636.00k
  • Lydia Stone (43yo)

    VP, Chief Accounting Officer & Corporate Controller

    • Tenure: 3.9yrs
  • Bob East

    Investor Contact

    • Tenure: 0.0yrs
  • John Johnson (35yo)

    Chief Financial Officer

    • Tenure: 0.1yrs

Board Members

  • Bruce Felt (61yo)

    Presiding Director

    • Tenure: 0.0yrs
    • Compensation: US$195.00k
  • Michael D’Amato (65yo)

    Independent Director

    • Tenure: 3.3yrs
    • Compensation: US$175.00k
  • Frank Williams (52yo)

    Co-Founder

    • Tenure: 8.0yrs
    • Compensation: US$3.31m
  • Cheryl Scott (69yo)

    Independent Director

    • Tenure: 3.8yrs
    • Compensation: US$175.00k
  • Matt Hobart (48yo)

    Independent Director

    • Tenure: 5.9yrs
  • Diane Holder (69yo)

    Director

    • Tenure: 8.0yrs
    • Compensation: US$190.00k
  • Ken Samet (61yo)

    Independent Director

    • Tenure: 3.9yrs
    • Compensation: US$175.00k
  • Seth Blackley (40yo)

    Co-Founder

    • Tenure: 1.3yrs
    • Compensation: US$2.21m
  • David Farner (55yo)

    Director

    • Tenure: 4.9yrs
    • Compensation: US$175.00k
  • M. Duffy (60yo)

    Independent Director

    • Tenure: 1.9yrs
    • Compensation: US$175.00k

Company Information

Evolent Health, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Evolent Health, Inc.
  • Ticker: 9EH
  • Exchange: DB
  • Founded: 2011
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: US$593.324m
  • Market Cap: US$528.176m
  • Listing Market Cap: US$532.627m
  • Shares outstanding: 84.52m
  • Website: https://www.evolenthealth.com

Number of Employees


Location

  • Evolent Health, Inc.
  • 800 North Glebe Road
  • Suite 500
  • Arlington
  • Virginia
  • 22203
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EVHNYSE (New York Stock Exchange)YesClass A Common StockUSUSDJun 2015
9EHDB (Deutsche Boerse AG)YesClass A Common StockDEEURJun 2015

Biography

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Heal ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/25 21:36
End of Day Share Price2019/08/23 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.